Suche

7574 Treffer – Seite 432 von 632

Mesh-Covered-Stents versus Drug-Eluting-Stents in koronar-venösen Bypassgefäßen. Eine läsionsbasierte Analyse des prozeduralen und stationären Outcomes

Gremlin promotes inflammation and cardiac remodeling leading to an increased cardiovascular risk in patients with non-ischemic cardiomyopathy

Impact of chronic kidney insufficiency on the endothelial function of saphenous vein grafts in coronary artery bypass grafting

Sex-specific differences in the prognostic value of pathological pre-hospital ECGs in the diagnosis of non-ST elevation myocardial infarction requiring percutaneous coronary intervention

Calpain inhibition in a transgenic model of calpastatin overexpression augments reversal of myocardial hypertrophy

Effects of empagliflozin in a rat model of heart failure with preserved ejection fraction: Focus on excitation-contraction coupling and mitochondrial function

Automated Template Matching versus Conventional Pace-Mapping during PVC Ablation:Results from a randomized controlled trial

Rat animal model for heart failure with preserved ejection fraction (HEpEF): A matter of diet

Effects of semaglutide and peptide YY in a rat model of heart failure with preserved ejection fraction: Focus on excitation-contraction coupling and mitochondrial function

Growth differentiation factor 15 (GDF15) is elevated in human plaques, shuffles into the nucleus of ECs during EndMT, and promotes Endothelial-to-Mesenchymal Transition (EndMT)

CRIP1 associates to endothelial dysfunction in humans and has an impact on endothelial dependent aortic relaxation in hypertensive mouse model

Effects of semaglutide in a rat model of heart failure with preserved ejection fraction: Focus on excitation-contraction coupling and mitochondrial function

1
...
430
431
432
433
434
435
436
437
438
439
440
450
460
470
480
490
500
600
...
632

Das Portal für Herzmedizin und Herzgesundheit.

Betrieben von der HKM - Herz-Kreislauf-Medizin gGmbH

*Jeder Förderer unterstützt Herzmedizin.de mit 150.000 Euro jährlich. Die Förderer haben keinerlei Einfluss auf die Themengestaltung und die redaktionellen Inhalte des Portals.